Results 141 to 150 of about 44,817 (277)
Daratumumab for CD20−CD38+ Relapsed/Refractory Diffuse Large B‐Cell Lymphoma
ABSTRACT Patients with R/R DLBCL (relapsed/refractory diffuse large B‐cell lymphoma) treated with rituximab‐based regimens often have a reduction in the expression level of CD20. Replacement of target proteins for new targeted chemotherapy has become a popular direction for the treatment of R/R DLBCL.
ZeTong Hong +9 more
wiley +1 more source
Severe pancytopenia triggered by recombinant hepatitis B vaccine [PDF]
Jean‐François Viallard +7 more
openalex +1 more source
PANCYTOPENIA AND VALPROIC ACID: A DOSE‐RELATED ASSOCIATION [PDF]
Oloruntoba Oluboka +2 more
openalex +1 more source
Clinicopathological Conference: A Previously Healthy Man with Fever and Pancytopenia [PDF]
R C Butler, Elizabeth Buetow
openalex +1 more source
Cardiac Angiosarcoma: A Diagnostic and Therapeutic Challenge
The Kaohsiung Journal of Medical Sciences, Volume 41, Issue 10, October 2025.
Kang Ying Tan, Yi‐Chang Liu
wiley +1 more source
Introduction: Pancytopenia is a manifestation of many serious & life threatening diseases with an extensive differential diagnosis. Major causes of pancytopenia in developing countries are megaloblastic anemia, parasitic infection, hypersplenism and ...
Bhaskar B Thakkar +3 more
doaj
Pyrexia and pancytopenia with unusual host immune response [PDF]
Zeba N. Singh +3 more
openalex +1 more source

